Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.465 AUD | -0.34% | -2.01% | +12.69% |
Apr. 30 | Wilsons Upgrades Monash IVF to Overweight from Market-Weight, Price Target is AU$1.58 | MT |
Apr. 12 | RBC Capital Markets Starts Monash IVF Group at New Sector Perform, Price Target is AU$1.50 | MT |
Sales 2024 * | 254M 170M | Sales 2025 * | 274M 183M | Capitalization | 571M 382M |
---|---|---|---|---|---|
Net income 2024 * | 27M 18.07M | Net income 2025 * | 32M 21.41M | EV / Sales 2024 * | 2.41 x |
Net Debt 2024 * | 41.72M 27.92M | Net Debt 2025 * | 31.24M 20.9M | EV / Sales 2025 * | 2.2 x |
P/E ratio 2024 * |
21
x | P/E ratio 2025 * |
17.5
x | Employees | 867 |
Yield 2024 * |
3.42% | Yield 2025 * |
4.05% | Free-Float | 92.72% |
Latest transcript on Monash IVF Group Limited
1 day | -0.34% | ||
1 week | -2.01% | ||
1 month | +1.74% | ||
3 months | +1.74% | ||
6 months | +13.13% | ||
Current year | +12.69% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Knaap
CEO | Chief Executive Officer | - | 15-08-30 |
Malik Jainudeen
DFI | Director of Finance/CFO | - | 14-03-31 |
Thierry Panthier
CTO | Chief Tech/Sci/R&D Officer | - | 19-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Neil Broekhuizen
BRD | Director/Board Member | 58 | 14-06-03 |
Richard Davis
CHM | Chairman | 68 | 14-06-03 |
Richard Henshaw
BRD | Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 1.465 | -0.34% | 252,352 |
24-05-16 | 1.47 | -0.68% | 188,546 |
24-05-15 | 1.48 | -0.67% | 376,734 |
24-05-14 | 1.49 | -0.33% | 225,378 |
24-05-13 | 1.495 | 0.00% | 274,691 |
Delayed Quote Australian S.E., May 17, 2024 at 02:10 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.69% | 382M | |
+19.28% | 84.56B | |
-26.95% | 72.41B | |
+4.65% | 27.75B | |
-7.35% | 17.75B | |
-0.46% | 17.11B | |
+4.69% | 16.03B | |
+8.14% | 13.72B | |
+6.59% | 12.91B | |
+70.00% | 12.55B |
- Stock Market
- Equities
- MVF Stock